Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Infectious Diseases

    At the Top of the COVID-19 Research Agenda: Asymptomatic Spread and Long-Term Health Impacts

    By Global Biodefense StaffJanuary 26, 2021
    Delivery of vaccine to priority groups during the early rollout of COVID-19 Operation Warp Speed. Credit: Ricardo Reyes / WRMMC
    Share
    Facebook LinkedIn Reddit Email

    A new research agenda developed by 40 leading experts in healthcare epidemiology and infectious diseases defines the critical areas of study to inform clinical practice, policy, and prevention strategies for COVID-19 and future pandemics.

    “COVID-19 Research Agenda for Healthcare Epidemiology,” published today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America (SHEA), identifies the gaps in the understanding of the epidemiology, transmission, and individual as well as public health consequences of viral diseases that were revealed through some of the worst phases of the COVID-19 pandemic.

    “The emergence and rapid world-wide spread of severe acute respiratory syndromewe coronavirus 2 (SARS-CoV-2) has led to unprecedented loss of life and socio/economic disruption. The scientific community has risen to this challenge and published an enormous body of work over the past year informing our response to the pandemic and leading to evolving guidelines for treatment, testing, and prevention,” said Lona Mody, MD, an author of the research agenda. “Looking to the future, the community still has much to learn. We must be intentional with our approach to improve how we prevent and treat COVID-19 and other viral illnesses.”

    The SHEA Research Committee assembled a working group of experts in the field of healthcare epidemiology to identify immediate research priorities in epidemiology, outbreak investigation, surveillance, isolation precaution practices, personal protective equipment, environmental contamination and disinfection, drug and supply shortages, antimicrobial stewardship, healthcare personnel occupational safety, and return to work policies. The thought leaders highlighted three critical research questions in each of these 10 areas.

    Among the most pressing areas for research, include:

    • Understanding the spread of the virus through asymptomatic and pre-symptomatic patients infected with COVID-19.
    • Determining how risk factors impact disease severity, as well as understanding long-term cardiometabolic, respiratory, neurological, and psychological impacts of the virus.
    • Developing tools to identify outbreaks more rapidly in hospitals, nursing homes, and other healthcare settings leading to early interventions to curtail outbreaks.
    • Improving the understanding of personal protective equipment, or PPE, including socio-behavioral reasons for not following PPE guidance, as well as the continued need for PPE during and after the pandemic.

    “This research agenda calls for translational studies from laboratory-based basic science research to well-designed, large-scale studies and health outcomes research,” said Deverick Anderson, MD, MPH, the senior author of the research agenda. “To undertake this work, funding organizations must make COVID-19 research their highest priority.”

    The authors note that this research agenda, while a significant tool for shaping the direction of the scientific literature, represents expert opinion at a moment in time during the worst days of the COVID-19 pandemic. They note that priorities may shift as the pandemic evolves and as vaccines and other therapeutics become available.

    COVID-19 Research Agenda for Healthcare Epidemiology. Infection Control & Hospital Epidemiology, 25 January 2021.

    COVID Countermeasures COVID-19 Editor Pick Epidemiology SARS-CoV-2 Transmission Dynamics
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleDefense Threat Reduction Agency Awards $75M for Antibiotic Drug Development
    Next Article In Tight Spaces, Air Purifiers May Do More Harm Than Good in Spreading Viruses

    Related Stories

    EPA Developing AMR Risk Framework for Antibacterial and Antifungal Pesticides

    September 29, 2023

    Provide Feedback on Federal DURC Biosafety Oversight of Potential Pandemic Pathogens

    September 24, 2023

    Committee to Examine Transmission and Geographic Spread of Chronic Wasting Disease

    September 24, 2023

    New Method Improves Quantification of Ricin in Complex Matrices

    September 20, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy